Aardvark Therapeutics, Inc. AARD
Set alert
1.20 USD -0.16 -11.76%
At close · Nov 2
1.25 +0.05 +4.17%
After hours · Nov 2, 6:41 PM ET
1.20 Day range 1.40
0.93 52-week range 16.60
- YTD
- -90.86%
- 1 year
- -88.77%
- Open
- 1.37
- Prev close
- 1.36
- Mkt cap
- 26.26M
- Vol
- 343.52K
- Avg vol
- 592.00K
- EPS
- -3.21
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.20
- High
- 1.40
1m chart
Built from the cached one-day intraday bars.
Signals (19)
| Name | Time | Ago |
|---|---|---|
| MACD: Buy Signal | Nov 2, 11:05 AM | 8 hours ago |
| RSI: Oversold | Nov 2, 10:55 AM | 8 hours ago |
| RSI: Oversold | Nov 2, 10:52 AM | 8 hours ago |
| RSI: Oversold | Nov 2, 10:49 AM | 8 hours ago |
| MACD: Sell Signal | Nov 2, 10:48 AM | 8 hours ago |
| MACD: Buy Signal | Nov 2, 10:39 AM | 8 hours ago |
| SMA: Bearish | Nov 2, 10:27 AM | 9 hours ago |
| SMA: Bearish | Nov 2, 10:27 AM | 9 hours ago |
| MACD: Sell Signal | Nov 2, 10:27 AM | 9 hours ago |
| SMA: Bullish | Nov 2, 10:26 AM | 9 hours ago |
| SMA: Bullish | Nov 2, 10:26 AM | 9 hours ago |
| MACD: Buy Signal | Nov 2, 10:26 AM | 9 hours ago |
| MACD: Sell Signal | Nov 2, 10:21 AM | 9 hours ago |
| SMA: Bearish | Nov 2, 10:19 AM | 9 hours ago |
| SMA: Bearish | Nov 2, 10:19 AM | 9 hours ago |
| RSI: Overbought | Nov 2, 10:12 AM | 9 hours ago |
| SMA: Bullish | Nov 2, 10:09 AM | 9 hours ago |
| SMA: Bullish | Nov 2, 10:09 AM | 9 hours ago |
| RSI: Oversold | Nov 2, 10:06 AM | 9 hours ago |
Financials — quick view
AARD Revenue — quarterly 0
AARD Net income — quarterly -14.39M
AARD EPS — quarterly -0.66
News
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- 12 Health Care Stocks Moving In Monday's Intraday Session
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- HC Wainwright & Co. Maintains Neutral on Aardvark Therapeutics, Lowers Price Target to $2
- Aardvark Therapeutics, Inc. (AARD) Discusses Efficacy and Safety Data From Terminated HERO Phase III and Open-Label Extension Trials Transcript
- 12 Health Care Stocks Moving In Friday's Intraday Session
- Aardvark Therapeutics Says Current Prader-Willi Syndrome Drug Data Insufficient
- Aardvark Therapeutics Says Current Prader-Willi Syndrome Drug Data Insufficient
- Dow Tumbles Over 500 Points; American Express Shares Fall After Q3 Results
- 12 Health Care Stocks Moving In Friday's Pre-Market Session
Your note
Sign in to keep a note on AARD — it syncs with the Stock Master app.